The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Hims & Hers faced backlash over its Super Bowl ad touting its compound weight loss drug while slamming pharmaceutical giants ...

Hims & Hers Health (HIMS) stock courts controversy as its Super Bowl commercial for weight loss products draws lawmaker ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) ...

When I spoke with Mike Chi, Hims’s chief commercial officer, he leaned hard into words such as normalization and empower. I told him that the constant barrage of Hims ads had made me feel almost ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Shares of Hims & Hers Health (NYSE:HIMS) rallied to reach an all-time high on Friday as the telehealth firm is set to debut its controversial TV commercial 'Sick of the System' during the upcoming ...

Hims & Hers' “Sick of the System” spot not only generated the highest engagement of all pharma-related ads that aired during ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Hims & Hers has capitalized on the outsize consumer demand for obesity drugs. (Hims & Hers Health) Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug ...